Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 9/5/2019

Budget: $5,000,000

Opportunity: PAS-18-188

This Funding Opportunity Announcement (FOA) encourages applications to NIA’s Small Business Technology Transfer Research (STTR) program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer’s disease (AD) and Alzheimer’s-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.

Leave a Reply